Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma

Table 1 Clinicopathological parameters of hepatocellular carcinoma patients in each cohort

Variables		Training group (n = 184)	Test group (n = 186)	Entire group (n = 370)
Age, yr	< 60	84	85	169
	≥ 60	100	101	201
Sex	Male	129	120	24
	Female	55	66	121
Weight, kilograms	< 70	92	85	177
	≥ 70	78	89	167
	NA	14	12	26
Child-Pugh grade	A	109	107	216
	B	9	12	21
	C	0	1	1
	NA	66	66	132
Fibrosis ishak score	0	32	42	74
	1-5	38	31	69
	6	36	33	69
	NA	78	80	158
Vascular tumor invasion	None	100	106	206
	Micro	45	46	91
	Macro	8	9	17
	NA	31	25	56
Serum FAP level, ng/mL	< 100	102	90	192
	≥ 100	37	48	85
	NA	45	48	93
Tumor grade	1	37	18	55
	2	82	95	177
	3 + 4	61	72	133
	NA	4	1	5
Pathologic stage	I	92	79	171
	II	43	42	85
	III + IV	37	53	90
	NA	12	12	24